SEROTONIN RESPONSE IN SWEET-FOOD CRAVING ALZHEIMERS-DISEASE SUBJECTS

被引：8

作者：

COOPER, JK

MUNGAS, D

机构：

[1] Department of Internal Medicine, University of California Davis Medical Center, Sacramento, California

[2] National Institute on Aging, Bethesda, Maryland, 20892, Bldg. 31

来源：

AGING-CLINICAL AND EXPERIMENTAL RESEARCH | 1992年 / 4卷 / 02期

关键词：

ALZHEIMERS DISEASE; DIETARY BEHAVIOR; FENFLURAMINE; PROLACTIN; SEROTONIN;

D O I：

10.1007/BF03324086

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

Abnormal sweet-food craving may occur in subjects with Alzheimer's disease. This behavior may be due to abnormalities in the brain serotonin system. Fenfluramine stimulates the brain serotonin neurosystem, producing an increase in systemic prolactin. Using the fenfluramine stimulation test, brain serotonin system response was evaluated in 12 subjects with probable Alzheimer's disease. The subjects' caregivers completed questionnaires concerning subject food preferences and behaviors. Alzheimer's disease subjects with sweet-food craving were found to. have a significantly higher response to fenfluramine than non sweet-food craving subjects. This preliminary study is limited by small sample size. Allowing for assumptions concerning central nervous system regulatory processes, the data suggest a possible role for the serotonin system in sweet-food craving in Alzheimer's disease.

引用

页码：165 / 169

页数：5

共 34 条

[11]

Cooper S.J., Drugs interacting with 5HT systems show promise for treatment of eating disorders, TIPS, 10, pp. 56-57, (1989)

[12]

Wurtman J.J., Wurtman R.J., Drugs that enhance central serotoninergic transmission diminish elective carbohydrate consumption by rats, Life Sci., 24, pp. 895-904, (1979)

[13]

Kaye W.H., Gwirtsman H.E., George D.T., The effect of bingeing and vomiting on hormonal secretion, Biol. Psychiatry, 25, pp. 768-780, (1989)

[14]

Morley J.E., Neuropeptide regulation of appetite and weight, Endocr. Rev., 8, pp. 256-287, (1987)

[15]

Ceci F., Cangiano C., Cairella M., Cascino A., Del Ben M., Muscaritoli M., Sibilia L., Fanelli F.R., The effects of oral 5 hydroxytryptophan administration on feeding behavior in obese adult female subjects, J. Neural Transm., 76, pp. 109-117, (1989)

[16]

Quattrone A., Tedeschi G., Aguglia U., Scopacasa F., DiRenzo G.F., Annunziato L., Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5-hydroxytryptaminergic neurones. Studies with fenfluramine, Br. J. Clin. Pharmacol., 16, pp. 471-475, (1983)

[17]

Coccaro E.F., Siever L.J., Klar H.M., Maurer G., Cochrane K., Cooper T.B., Mohs R.C., Davis K.L., Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior, Arch. Gen. Phsychiatry, 36, pp. 587-599, (1989)

[18]

McBride P.A., Tierney H., DeMeo M., Chen J.S., Mann J.J., Effects of age and gender on CNS serotonergic responsivity in normal adults, Biol. Psychiatry, 27, pp. 1143-1155, (1990)

[19]

Takahashi R., Tateishi T., Yoshida H., Effects of chronic treatment with antidepressant drugs on serotonergic receptor binding activity in normal and tetrabenazine depressed rats, New Vistas in Depression, pp. 29-36, (1982)

[20]

Roth B.L., McLean S., Zhu X., Chuang D-M, Characterization of two [3H] ketanserin recognition sites in rat striatum, J. Neurochem., 49, pp. 1833-1838, (1987)

← 1 2 3 4 →